Modified ionic liquid cold-induced aggregation dispersive liquid-liquid microextraction followed by atomic absorption spectrometry for trace determination of zinc in water and food samples

Utilization of a novel PVC- optical sensor for high sensitive and selective determination of zinc ion in real samples

A novel and highly specific bulk membrane optode was developed for the ultra-sensitive detection of zinc(II) in biological, pharmaceutical, and water samples. The polymer inclusion membrane (PIM) utilized in this study consists of 50% polyvinyl chloride (PVC) as a base polymer, 9.00% DOP (dioctylphthalate) as the plasticizer, and 40.0% D2EHPA (di(2-ethlyhexyl)phosphoric acid) as the carrier. To facilitate the spectrophotometric determination of zinc(II), a colorimetric reagent, namely 4-(2-arsonophenylazo) salicylic acid (APASA) {1.00%, m/v}, was employed. When Zn(II) was extracted into the PIM, it led to the creation of the zinc-D2EHPA complex. This complex then underwent a reaction with APASA, resulting in the formation of a red Zn - APASA complex with a maximum absorption wavelength (λmax) of 558 nm. To optimize the response of the optode, a central composite design was employed, considering variables such as the amount of additive and reagent, response time, and pH. When operated under the specific optimal conditions, the sensor demonstrated a limit of quantification (LOQ) of 0.74 ng/mL (equivalent to 1.17 × 10-8 M) and a limit of detection (LOD) of 0.22 ng/mL (equivalent to 3.44 × 10-9 M). The optode membrane demonstrated excellent reproducibility, stability, and a relatively long lifespan, making it suitable for precise and accurate monitoring of Zn(II) ion content. Regeneration of the optode was achieved effectively using 0.25 nitric acid solution, and its response exhibited reversibility and reproducibility, showed a relative standard deviation of less than 1.33%. Moreover, the PIM-APASA optode exhibited a high level of effectiveness in accurately determining the presence of Zn(II) ions in real environmental samples.

Silica-coated magnetic iron oxide functionalized with hydrophobic polymeric ionic liquid: a promising nanoscale sorbent for simultaneous extraction of antidiabetic drugs from human plasma prior to their quantitation by HPLC

Herein, silica-coated iron oxide nanoparticles modified with imidazolium-based polymeric ionic liquid (Fe₃O₄@SiO₂@PIL) were fabricated as a sustainable sorbent for magnetic solid-phase extraction (MSPE) and simultaneous determination of trace antidiabetic drugs in human plasma by high-performance liquid chromatography-ultraviolet detection (HPLC-UV). The Fe₃O₄ core was functionalized by silica (SiO₂) and vinyl layers where the ionic liquid 1-vinyl-3-octylimidazolium bromide (VOIM-Br) was attached through a free radical copolymerization process. In order to achieve hydrophobic magnetic nanoparticles and increase the merits of the sorbent, Br⁻ anions were synthetically replaced with PF₆⁻. The properties and morphology of the sorbent were characterized by various techniques and all the results illustrated the prosperous synthesis of Fe₃O₄@SiO₂@PIL. A comprehensive study was carried out to investigate and optimize various parameters affecting the extraction efficiency. The limit of detection (LOD, S/N = 3) for empagliflozin, metformin and canagliflozin was 1.3, 6.0 and 0.8 ng mL⁻¹, respectively. Linearity (0.997 ≥ r² ≥ 0.993) and linear concentration ranges of 5.0–1200.0, 20.0–1800.0 and 5.0–1000.0 ng mL⁻¹ were obtained for empagliflozin, metformin and canagliflozin, respectively. Intra-assay (3.8–7.5%, n = 9) and inter-assay (3.2–8.5%, n = 12) precisions as well as accuracies (≤9.1%) displayed good efficiency of the method. Finally, the method was applied for the quantitation of antidiabetic drugs in human plasma after oral administration and main pharmacokinetic data including T_max (h), C_max (ng mL⁻¹), AUC_0–24 (ng h mL⁻¹), AUC_0–∞ (ng h mL⁻¹), and T_1/2 (h) were evaluated.

A sustainable nanoscale core–shell modified with hydrophobic polymeric ionic liquid was fabricated for simultaneous extraction and determination of antidiabetic drugs.

Ionic liquid phase microextraction combined with fluorescence spectrometry for preconcentration and quantitation of carvedilol in pharmaceutical preparations and biological media

BACKGROUND

Carvedilol belongs to a group of medicines termed non-selective beta-adrenergic blocking agents. In the presented approach, a practical and environmentally friendly microextraction method based on the application of ionic liquids (ILs) was followed by fluorescence spectrometry for trace determination of carvedilol in pharmaceutical and biological media.

METHODS

A rapid and simple ionic liquid phase microextraction was utilized for preconcentration and extraction of carvedilol. A hydrophobic ionic liquid (IL) was applied as a microextraction solvent. In order to disperse the IL through the aqueous media and extract the analyte of interest, IL was injected into the sample solution and a proper temperature was applied and then for aggregating the IL-phase, the sample was cooled in an ice water-bath. The aqueous media was centrifuged and IL-phase collected at the bottom of the test tube was introduced to the micro-cell of spectrofluorimeter, in order to determine the concentration of the enriched analyte.

RESULTS

Main parameters affecting the accuracy and precision of the proposed approach were investigated and optimized values were obtained. A linear response range of 10-250 μg I(-1) and a limit of detection (LOD) of 1.7 μg I(-1) were obtained.

CONCLUSION

Finally, the presented method was utilized for trace determination of carvedilol in commercial pharmaceutical preparations and biological media.

Quantitative analysis of piroxicam using temperature-controlled ionic liquid dispersive liquid phase microextraction followed by stopped-flow injection spectrofluorimetry

BACKGROUND

Piroxicam (PXM) belongs to the wide class of non-steroidal anti-inflammatory drugs (NSAIDs). PXM has been widely applied in the treatment of rheumatoid arthritis, gonarthrosis, osteoarthritis, backaches, neuralgia, mialgia. In the presented work, a green and benign sample pretreatment method called temperature-controlled ionic liquid dispersive liquid phase microextraction (TCIL-DLPME) was followed with stopped-flow injection spectrofluorimetry (SFIS) for quantitation of PXM in pharmaceutical formulations and biological samples.

METHODS

Temperature-controlled ionic liquid dispersive liquid phase microextraction (TCIL-DLPME) was applied as an environmentally friendly sample enrichment method to extract and isolate PXM prior to quantitation. Dispersion of 1-hexyl-3-methylimidazolium hexafluorophosphate ([Hmim][PF6]) ionic liquid (IL) through the sample aqueous solution was performed by applying a relatively high temperature. PXM was extracted into the extractor, and after phase separation, PXM in the final solution was determined by stopped-flow injection spectrofluorimetry (SFIS).

RESULTS AND MAJOR CONCLUSION

Different factors affecting the designed method such as IL amount, diluting agent, pH and temperature were investigated in details and optimized. The method provided a linear dynamic range of 0.2-150 μg l-1, a limit of detection (LOD) of 0.046 μg l-1 and a relative standard deviation (RSD) of 3.1%. Furthermore, in order to demonstrate the analytical applicability of the recommended method, it was applied for quantitation of PXM in real samples.